[go: up one dir, main page]

PL367702A1 - Combination of a taxane and a cyclin-dependent kinase - Google Patents

Combination of a taxane and a cyclin-dependent kinase

Info

Publication number
PL367702A1
PL367702A1 PL02367702A PL36770202A PL367702A1 PL 367702 A1 PL367702 A1 PL 367702A1 PL 02367702 A PL02367702 A PL 02367702A PL 36770202 A PL36770202 A PL 36770202A PL 367702 A1 PL367702 A1 PL 367702A1
Authority
PL
Poland
Prior art keywords
taxane
cyclin
combination
dependent kinase
kinase
Prior art date
Application number
PL02367702A
Other languages
Polish (pl)
Other versions
PL206118B1 (en
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL367702A1 publication Critical patent/PL367702A1/en
Publication of PL206118B1 publication Critical patent/PL206118B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL367702A 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase PL206118B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (2)

Publication Number Publication Date
PL367702A1 true PL367702A1 (en) 2005-03-07
PL206118B1 PL206118B1 (en) 2010-07-30

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
PL367702A PL206118B1 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase

Country Status (33)

Country Link
US (2) US20020182204A1 (en)
EP (1) EP1372652B1 (en)
JP (1) JP2004521140A (en)
KR (1) KR100879712B1 (en)
CN (1) CN1498107A (en)
AR (1) AR034222A1 (en)
AT (1) ATE395917T1 (en)
AU (1) AU2002312815B2 (en)
BR (1) BR0208221A (en)
CA (1) CA2441441C (en)
CY (1) CY1110449T1 (en)
CZ (1) CZ301423B6 (en)
DE (1) DE60226710D1 (en)
DK (1) DK1372652T3 (en)
EA (1) EA007815B1 (en)
ES (1) ES2305253T3 (en)
HR (1) HRPK20030766B3 (en)
HU (1) HU229258B1 (en)
IL (2) IL158058A0 (en)
ME (1) MEP16408A (en)
MX (1) MXPA03007743A (en)
NO (1) NO332441B1 (en)
NZ (1) NZ527655A (en)
PE (1) PE20020907A1 (en)
PL (1) PL206118B1 (en)
PT (1) PT1372652E (en)
RS (1) RS50681B (en)
SI (1) SI1372652T1 (en)
SK (1) SK287481B6 (en)
TW (1) TWI355935B (en)
UY (1) UY27220A1 (en)
WO (1) WO2002076484A2 (en)
ZA (1) ZA200307381B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075943A2 (en) * 2002-03-06 2003-09-18 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
AU2003276467A1 (en) * 2002-11-06 2004-06-07 Cyclacel Limited Combination comprising docetaxel and a cdk inhibitor
JP5537035B2 (en) * 2006-02-10 2014-07-02 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ A combination comprising a CDK inhibitor and a growth factor antibody or anti-mitotic agent
MX2013005661A (en) * 2010-11-19 2013-09-13 Piramal Entpr Ltd PHARMACEUTICAL COMBINATION OF PACLITAXEL AND A CDK INHIBITOR (CYCLINE DEPENDENT KINASE).
HRP20191927T1 (en) * 2011-04-01 2020-01-10 Astrazeneca Ab THERAPEUTIC TREATMENT
PL2785349T5 (en) 2011-11-30 2023-01-30 Astrazeneca Ab Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX9102128A (en) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.
WO1997030174A1 (en) * 1996-02-20 1997-08-21 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Also Published As

Publication number Publication date
NO332441B1 (en) 2012-09-17
MEP16408A (en) 2010-10-10
KR20030086318A (en) 2003-11-07
EP1372652A2 (en) 2004-01-02
PT1372652E (en) 2008-07-24
ATE395917T1 (en) 2008-06-15
BR0208221A (en) 2004-03-02
IL158058A0 (en) 2004-03-28
US20020182204A1 (en) 2002-12-05
ZA200307381B (en) 2005-03-30
DE60226710D1 (en) 2008-07-03
HUP0303589A2 (en) 2004-03-01
HRPK20030766B3 (en) 2006-11-30
HU229258B1 (en) 2013-10-28
HUP0303589A3 (en) 2007-05-02
YU69503A (en) 2006-08-17
CY1110449T1 (en) 2015-04-29
HRP20030766A2 (en) 2005-06-30
JP2004521140A (en) 2004-07-15
NO20034124L (en) 2003-09-16
CZ301423B6 (en) 2010-02-24
RS50681B (en) 2010-06-30
KR100879712B1 (en) 2009-01-22
CA2441441C (en) 2009-05-26
NO20034124D0 (en) 2003-09-16
DK1372652T3 (en) 2008-09-22
SK11692003A3 (en) 2004-03-02
EA200301053A1 (en) 2004-02-26
AU2002312815B2 (en) 2006-08-24
CZ20032551A3 (en) 2004-07-14
EP1372652B1 (en) 2008-05-21
TWI355935B (en) 2012-01-11
PL206118B1 (en) 2010-07-30
UY27220A1 (en) 2002-09-30
SK287481B6 (en) 2010-11-08
AR034222A1 (en) 2004-02-04
NZ527655A (en) 2006-03-31
CA2441441A1 (en) 2002-10-03
PE20020907A1 (en) 2002-12-19
CN1498107A (en) 2004-05-19
WO2002076484A2 (en) 2002-10-03
EA007815B1 (en) 2007-02-27
MXPA03007743A (en) 2004-11-12
SI1372652T1 (en) 2008-10-31
IL158058A (en) 2010-02-17
ES2305253T3 (en) 2008-11-01
US20060128640A1 (en) 2006-06-15
WO2002076484A3 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
MXPA03006420A (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
SG111920A1 (en) Authentication of electronic documents
AU2002332749A1 (en) Package with integrated inductor and/or capacitor
GB0121789D0 (en) Electronic paymetn authorisation
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
EP1390052A4 (en) Inhibition of jun kinase
SG100745A1 (en) Ceramic composition and ceramic capacitor
EP1392317A4 (en) Substituted 1-benzazepines and derivatives thereof
PL367702A1 (en) Combination of a taxane and a cyclin-dependent kinase
GB0126889D0 (en) Compounds and their uses
GB0123657D0 (en) Worktool
GB2376928B (en) Personal hoverplane having four tiltmotors
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
IL158239A0 (en) Zonisamide intermediate and synthesis
PL367639A1 (en) Novel heterocyclic compound and medicinal use thereof
EP1381061A4 (en) Inductance element and case
GB0115234D0 (en) Electronic authorisation
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
EP1421101A4 (en) P-glycoproteins and uses thereof
IL156839A0 (en) Use of chromanes
EP1392460A4 (en) Hydrogenfluorides of aminosilanols and their use
ZA200305379B (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
HU0104370D0 (en) Honeyed schnaps of oerseg
TW573751U (en) Structure capable of preventing jaming

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140322